Company Atlasby KadoaStar on GitHub

Bio-Techne TECH

Bio-Techne is the 477th largest S&P 500 company by market cap, worth $11.4 billion. 9 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 5 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 11.6% of the company.

CEO
Kim Kelderman
Sector
Health Care
Sub-industry
Life Sciences Tools & Services
Headquarters
Minneapolis, Minnesota
Founded
1976
More
Wikipedia
Market cap
$11.4B
477th largest, 23 Oct 2026 close
Revenue
$1.2B
Fiscal year 2026
Price to sales
9.4
Market cap over revenue
Employees
3,000
10-K, 30 Jun 2026
Market cap per employee
$3.8M
Market cap over employees
Connections
1
S&P 500 companies sharing a director or officer

Largest institutional holders

Each fund group's share of Bio-Techne. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 37.8% of Bio-Techne.

Source: SEC Form 13F data sets, SEC XBRL shares outstanding 路 All holders

Board and officers

1 person here also holds roles at other S&P 500 companies.

Roles filed up to 30 Sep 2026

NameTitle
Directors (9)
Kim KeldermanChief Executive OfficerChief Executive Officer
Robert V. BaumgartnerDirectorDirector
Julie L. BushmanDirectorAlso at Phillips 66Last filed 3 Nov 2025Director
Amy E. HerrDirectorDirector
John L. HigginsDirectorDirector
Joseph D. KeeganDirectorLast filed 3 Nov 2025Director
Judith V. KlimovskyDirectorLast filed 3 Nov 2025Director
Alpna SethDirectorLast filed 3 Nov 2025Director
Rupert VesseyDirectorLast filed 3 Nov 2025Director
Officers (5)
James HippelCFOLast filed 19 Aug 2026CFO
Shane BohnenSVP - General CounselLast filed 19 Aug 2026SVP - General Counsel
Steven C. CrousePresident - Diag & Spatial BiLast filed 19 Aug 2026President - Diag & Spatial Bi
William GeistPresident, Protein SciencesLast filed 19 Aug 2026President, Protein Sciences
Matthew McManusPresident - Diag & Spatial BioLast filed 3 Feb 2026President - Diag & Spatial Bio

Source: SEC insider filings (Forms 3, 4 and 5), Bio-Techne's Form 4 filings 路 All directors and officers

Companies that share people with Bio-Techne

Each person's title here, then at the other company.

  • Phillips 66 PSX
    • Julie L. Bushman: Director here, Director there

Source: SEC insider filings 路 See the whole network

Bio-Techne's market cap since December 2008

Weekly, up to 23 Oct 2026

Show equal percentage changes as equal steps.
201020122014201620182020202220242026$11.4B

Source: Yahoo Finance closing prices, SEC XBRL shares outstanding

Workforce

Headcount at 30 Jun 2026

Employees
3,000
In the US
2,200
Who is counted
Includes approximately 2,200 U.S. employees.
For more information, see Note 1 to our Consolidated Financial Statements as of and for the fiscal year ended June 30, 2026 and our proxy statement filed with the SEC on August 20, 2026.HUMAN CAPITAL Through its subsidiaries, Bio-Techne employed approximately 3,000 full-time and part-time employees as of June 30, 2026, of whom approximately 2,200 were employed in the U.S.
Bio-Techne Form 10-K

Source: Bio-Techne Form 10-K

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 30 Sep 2025 to 30 Sep 2026

Directors and officers sold $437,187 of stock in 2 sales and made no open-market purchases in the 12 months to 30 Sep 2026.

DatePersonTitleTypeSharesValue
8 May 2026SaleAmy E. HerrDirectorDirectorSale6,636$320K
17 Feb 2026SaleAmy E. HerrDirectorDirectorSale1,976$117K

Source: SEC insider transactions data sets, Bio-Techne's Form 4 filings

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 20 Oct 2023 to 20 Oct 2026

4 people disclosed 10 purchases and 11 sales of Bio-Techne stock since October 2023.

DateMember or officialTypeAmount
13 Apr 2026Rohit Khanna (House, D-CA)House, D-CA 路 SoldSale$1,001 to $15,000$1K to $15K
8 Apr 2026April McClain Delaney (House, D-MD)House, D-MD 路 SoldSale$1,001 to $15,000$1K to $15K
26 Mar 2026April McClain Delaney (House, D-MD)House, D-MD 路 SoldSale$1,001 to $15,000$1K to $15K
24 Feb 2026April McClain Delaney (House, D-MD)House, D-MD 路 SoldSale$1,001 to $15,000$1K to $15K
29 Jan 2026Rohit Khanna (House, D-CA)House, D-CA 路 BoughtPurchase$1,001 to $15,000$1K to $15K
28 Jan 2026April McClain Delaney (House, D-MD)House, D-MD 路 SoldSale$1,001 to $15,000$1K to $15K
5 Dec 2025April McClain Delaney (House, D-MD)House, D-MD 路 BoughtPurchase$1,001 to $15,000$1K to $15K
2 Dec 2025April McClain Delaney (House, D-MD)House, D-MD 路 BoughtPurchase$1,001 to $15,000$1K to $15K
22 Oct 2025April McClain Delaney (House, D-MD)House, D-MD 路 BoughtPurchase$1,001 to $15,000$1K to $15K
1 Aug 2025April McClain Delaney (House, D-MD)House, D-MD 路 SoldSale$1,001 to $15,000$1K to $15K

Showing 10 of 21 trades

Source: House, Senate and OGE disclosures via the Congress trading monitor

Not on file: no WARN layoff notices under its own name since October 2023.